ZOSBIO CE Troponin I Detection Reagent Myocardial Injury Detection
Protein
CTnI Overview
Cytokinin I (cTnI) is a special protein originated from
cardiomyocytes. It has extraordinary function to control the
contraction of cardiomyocytes. It is widely used in clinical
detection of myocardial injury and unstable angina pectoris. For
these patients, cTnI has the advantages of early onset,
persistence, myocardial specificity and long diagnostic cycle. It
is the first choice for the diagnosis of myocardial infarction.
CTnI Performance Index
| Detection range | sample size | Sample type | Test time |
| 0.1~50ng/mL | 60μl | Whole blood / serum / plasma | 15min |
CTnI Clinical Significance
Thrombin combined with ischemic evidence is helpful for the early
diagnosis and treatment of type I myocardial infarction. Mastering
the change law of exocrin is helpful to identify and diagnose
exocrin. For example, for temporary myocardial injury caused by
strenuous exercise, tachycardia and acute pulmonary embolism, CTN
will temporarily increase and return to normal within 1-2 days.
Chronic CTN elevation is caused by heart failure. These
characteristics can help us distinguish myocardial infarction.
- Preferred marker of myocardial infarction (MI)
- We measured the size of the infarct and stratified the risk.
- Prognosis of patients with AMI
Access to diagnosis and risk stratification of ACS (ESC guidelines
2007)
| See a doctor | Chest pain/chest tightness |
| Medical history and physical examination | Suspected ACS (Acute Coronary Syndrome) |
| electrocardiogram | Persistent ST segment elevation | Abnormal St/T segment ↓ |  | ECG normal ↓ |
| Biochemical test | ↓Confirm | CTN was positive | Troponin CTN negative ×2 |
| Risk stratification | high-risk | Low risk |
| diagnosis | ST-segment elevation myocardial infarction STEMI | Non-ST-segment elevation myocardial infarction NSTEMI | | Unstable angina pectoris UA |
| treatment | Reperfusion | Interventional therapy | Non-interventional therapy |
CTnI Advantages of clinical application
- Smaller molecular weight and longer time
- It is closely related to the degree of victimization
CTnI Reference
Ctnt<0.1 μg/L was normal, >0.2 μg/L was diagnostic off, and
>0.5 μg/L was diagnosed as acute myocardial infarction.
CTnI<0.2 μg/L was the normal value, and >1.5 μg/L was the
closed value of ELISA diagnosis.
Application Department
Cardiology, first aid, examination room, pediatrics, hematology,
oncology, Nephrology, surgery, etc
cTnI Clinical comparison
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
